← Back to Clinical Trials
Recruiting NCT07294001

NCT07294001 Shame-Focused Cognitive Behavioral Therapy For Reducing Suicide Risk In Adolescent Psychiatric Inpatients (SF-CBT)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07294001
Status Recruiting
Phase
Sponsor Peking University
Condition Adolescent Suicide
Study Type INTERVENTIONAL
Enrollment 42 participants
Start Date 2025-08-10
Primary Completion 2026-09-30

Trial Parameters

Condition Adolescent Suicide
Sponsor Peking University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 42
Sex ALL
Min Age 13 Years
Max Age 18 Years
Start Date 2025-08-10
Completion 2026-09-30
Interventions
Shame-Focused Cognitive Behavioral Therapy (SF-CBT)Supportive Therapy (ST)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This pilot randomized controlled trial (RCT) aims to evaluate the feasibility, acceptability, and preliminary efficacy of Shame-Focused Cognitive Behavioral Therapy (SF-CBT) among high-risk psychiatric inpatient adolescents. Shame has been identified as a critical psychological mechanism underlying suicidal ideation and behavior, yet few interventions directly target it. SF-CBT is a structured, manualized intervention designed to reduce shame, improve coping strategies, and lower suicide risk. Approximately 42 adolescents aged 13-18 years, admitted for recent suicide attempt or severe suicidal ideation, will be randomized in a 2:1 ratio to receive either SF-CBT or supportive therapy (ST). Both conditions include 7 individual sessions for adolescents and 3 structured psychoeducation sessions for parents/guardians. Primary outcomes include feasibility metrics (recruitment, retention, adherence, fidelity, adverse events) and acceptability ratings from adolescents, parents, and therapists. Secondary outcomes include changes in suicidal ideation, suicidal behavior, shame, and coping styles, assessed at baseline, post-treatment, and 1-, 3-, and 6-month follow-ups. Findings will inform refinement of the intervention manual, establish feasibility benchmarks, and provide effect size estimates to guide a subsequent large-scale RCT.

Eligibility Criteria

Inclusion Criteria: * Adolescents aged 13-18 years, male or female. * Recent suicide risk, defined as: At least one suicide attempt in the past month, or Current suicidal ideation within the past month (with or without plan/intent) and at least one previous attempt. * Elevated shame level (baseline score ≥ 9 on the External and Internal Shame Scale, EISS). * Adequate cognitive capacity to participate in interviews and assessments. * Parent/legal guardian (or designated responsible adult authorized by guardian) provides informed consent and agrees to participate. Exclusion Criteria: * Current manic episode. * History of schizophrenia spectrum disorder, intellectual disability, or organic brain disease. * Severe psychiatric or medical conditions that impair capacity for consent or participation. * Expected to receive electroconvulsive therapy (ECT) during hospitalization. * Anticipated inpatient stay shorter than 14 days (to ensure intervention completion).

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology